Recommendations for Use of Marginal Donors in Heart Transplantation: Brazilian Association of Organs Transplantation Guideline

被引:20
作者
Fiorelli, A. I.
Stolf, N. A. G.
Pego-Fernandes, P. M.
Oliveira Junior, J. L.
Santos, R. H. B.
Contreras, C. A. M.
Filho, D. D. L.
Dinkhuysen, J. J.
Moreira, M. C. V.
Mejia, J. A. C.
Castro, M. C. R.
机构
关键词
INTERNATIONAL SOCIETY; WAITING-LIST; OUTCOMES; REGISTRY; IMPACT; ALLOGRAFTS; SELECTION; SURVIVAL; CRITERIA; STRATEGY;
D O I
10.1016/j.transproceed.2010.12.047
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The high prevalence of heart failure has increased the candidate list for heart transplantation; however, there is a shortage of viable donated organs, which is responsible for the high mortality of patients a waiting a transplantation. Because the marginal donor presents additional risk factors, it is not considered to be an ideal donor. The use of a marginal donor is only justified in situations when the risk of patient death due to heart disease is greater than that offered by the donor. These recommendations sought to expand the supply of donors, consequently increasing the transplant rate. We selected articles based on robust evidence to provide a substratum to develop recommendations for donors who exceed the traditional acceptance criteria. Recipient survival in the immediate postoperative period is intimately linked to allograft quality. Primary allograft failure is responsible for 38% to 40% of immediate deaths after heart transplantation: therefore; marginal donor selection must be more rigorous to not increase the surgical risk. The main donor risk factors with the respective evidence levels are: cancer in the donor (B), female donor (B), donor death due to hemorrhagic stroke (B), donor age above 50 years (relative risk [RR] = 1.5) (B), weight mismatch between donor and recipient < 0.8 (RR = 1.3) (B), ischemia > 240 minutes (RR = 1.2) (B), left ventricular dysfunction with ejection fraction below 45% (B), and use of high doses of vasoactive drugs (dopamine > 15 mg/kg . mm) (B). Factors that impact recipient mortality are: age over 50 years (RR = 1.5); allograft harvest at a distance; adult recipient weighing more than 20% of the donor; high doses of vasoactive drugs (dopamine greater than 15 mg/kg . min) and ischemic time >4 hours. The use of a marginal donor is only justified when it is able to increase life expectancy compared with clinical treatment, albeit the outcomes are interior to those using an ideal donor.
引用
收藏
页码:211 / 215
页数:5
相关论文
共 30 条
[1]   Cardiac Recovery in a Human Non-Heart-beating Donor After Extracorporeal Perfusion: Source for Human Heart Donation? [J].
Ali, Ayyaz ;
White, Paul ;
Dhital, Kumud ;
Ryan, Marian ;
Tsui, Steven ;
Large, Stephen .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (03) :290-293
[2]  
[Anonymous], 2005, Paediatr Child Health, V10, P335
[3]   Religious aspects of organ transplantation [J].
Bruzzone, P. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (04) :1064-1067
[4]   WEIGHT IS NOT AN ACCURATE CRITERION FOR ADULT CARDIAC TRANSPLANT SIZE MATCHING [J].
CHAN, BBK ;
FLEISCHER, KJ ;
BERGIN, JD ;
PEYTON, VC ;
FLANAGAN, TL ;
KERN, JA ;
TRIBBLE, CG ;
GIBSON, RS ;
KRON, IL .
ANNALS OF THORACIC SURGERY, 1991, 52 (06) :1230-1236
[5]   Alternate waiting list strategies for heart transplantation maximize donor organ utilization [J].
Chen, JM ;
Russo, MJ ;
Hammond, KM ;
Mancini, DM ;
Kherani, AR ;
Fal, JM ;
Mazzeo, PA ;
Pinney, SP ;
Edwards, NM ;
Naka, Y .
ANNALS OF THORACIC SURGERY, 2005, 80 (01) :224-228
[6]   Do donor characteristics really matter? Short- and long-term impact of donor characteristics on recipient survival, 1995-1999 [J].
Chen, JM ;
Sinha, P ;
Rajasinghe, HA ;
Suratwala, SJ ;
McCue, JD ;
McCarty, MJ ;
Caliste, X ;
Hauff, HM ;
John, R .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (05) :608-610
[7]   Outcomes with an alternate list strategy for heart transplantation [J].
Felker, GM ;
Milano, CA ;
Yager, JEE ;
Hernandez, AF ;
Blue, L ;
Higginbotham, MB ;
Lodge, AJ ;
Russell, SD .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (11) :1781-1786
[8]   Outcome of transplantation of organs procured from bacteremic donors [J].
Freeman, RB ;
Giatras, I ;
Falagas, ME ;
Supran, S ;
O'Connor, K ;
Bradley, J ;
Snydman, DR ;
Delmonico, FL .
TRANSPLANTATION, 1999, 68 (08) :1107-1111
[9]   RISK-FACTORS FOR GRAFT FAILURE ASSOCIATED WITH PULMONARY-HYPERTENSION AFTER PEDIATRIC HEART-TRANSPLANTATION [J].
FUKUSHIMA, N ;
GUNDRY, SR ;
RAZZOUK, AJ ;
BAILEY, LL .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (04) :985-989
[10]   Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients [J].
Gasink, Leanne B. ;
Blumberg, Emily A. ;
Localio, A. Russell ;
Desai, Shashank S. ;
Israni, Ajay K. ;
Lautenbach, Ebbing .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (15) :1843-1850